Ginzberg Sara P, Wirtalla Christopher J, Keele Luke J, Wachtel Heather, Kaufman Elinore J, Kelz Rachel R
Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, PA, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
Am J Surg. 2024 Jan;227:15-21. doi: 10.1016/j.amjsurg.2023.09.010. Epub 2023 Sep 12.
This comparative effectiveness study examined outcomes of operative vs. non-operative management for emergency general surgery (EGS) conditions in patients with recent cancer treatment (RT).
Medicare beneficiaries with a history of colorectal cancer hospitalized for an EGS condition (2016-2018) were identified. RT was defined as chemotherapy/radiation within 3 months prior to admission. Instrumental variable analysis assessed the impact of management on mortality and readmissions among survivors (30d, 60d, and 90d), for patients in whom there was clinical equipoise regarding optimal management strategy.
Of 26,097 patients, 13% had undergone RT. In both the RT and non-RT groups, the optimal management strategy was uncertain in 14%. Operative management conferred increased risk of mortality but not readmission in patients with RT compared to those without (90d mortality:+43%, p = 0.03; 90d readmission:+7.1%, p = 0.776).
In patients with RT for whom there is clinical equipoise regarding EGS management, operative intervention increases risk of mortality.
本比较有效性研究考察了近期接受癌症治疗(RT)的患者急诊普通外科(EGS)疾病的手术治疗与非手术治疗的结果。
确定2016 - 2018年因EGS疾病住院的有结直肠癌病史的医疗保险受益人。RT定义为入院前3个月内的化疗/放疗。对于最佳治疗策略存在临床 equipoise 的患者,采用工具变量分析评估治疗对幸存者(30天、60天和90天)死亡率和再入院率的影响。
在26097例患者中,13%接受过RT。在RT组和非RT组中,14%的患者最佳治疗策略不确定。与未接受RT的患者相比,接受RT的患者手术治疗会增加死亡风险,但不会增加再入院风险(90天死亡率:增加43%,p = 0.03;90天再入院率:增加7.1%,p = 0.776)。
对于EGS治疗存在临床 equipoise 的接受RT的患者,手术干预会增加死亡风险。